OAKLAND, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) — Promaxo Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced a four-year research collaboration with the University of Montreal Hospital Research Centre (CRCHUM) supporting MRI guided radiation oncology solutions for improved prostate cancer management, female genitourinary (“GU”) and obstetrics and gynecology (“OB/GYN”). The collaboration also aims to support Health Canada regulatory filing requirements. The strategic partnership received initial funding from the TransMedTech Institute, an organization focused on innovation and the development of medical technologies.
Dr. Cynthia Ménard, MD, Radiation Oncologist – Chief of the Radio-Oncology Department at the CHUM, researcher at CRCHUM and clinical professor at Université de Montréal, leads the clinical collaboration for CRCHUM that will focus on the design, development and validation of a low-field MRI system-based targeted interventions of cancers of the (i) prostate gland, and (ii) gynecological organs. “With this technology, we expect to improve the accuracy of image-guidance for needle navigation and brachytherapy, leading to improved patient outcomes in the future.”
Jean-François Carrier, PhD, MCCPM, Associate professor – Department of Physics, Université de Montréal and Chair holder of the TransMedTech Institute in medical imaging, is the scientific project leader. With proven expertise in brachytherapy physics and medical imaging development, he will lead a team of students and scientists for this collaboration. “Bringing this technology to our brachytherapy suite is exciting and will change the way we see in-room imaging for our cancer patients.”
“Our technology provides for compact, live MRI diagnosis and treatment in a physician’s office, with an open architecture to enable not only cancer management of the prostate, but also female GYN,” said Dr. Amit Vohra, Founder and CEO of Promaxo. “We hope to add additional applications to our mobile MRI technology and are thrilled to partner with the renowned team at CRCHUM to advance point of care MR based cancer care management.”
About the CRCHUM
The University of Montreal Hospital Research Centre (CRCHUM) is one of North America’s leading hospital research centres. It strives to improve adult health through a research continuum covering such disciplines as the fundamental sciences, clinical research and public health. Over 2,300 people work at the CRCHUM, including more than 500 researchers and more than 520 graduate students.
For more information, please visit chumontreal.qc.ca/crchum and follow @CRCHUM on Twitter.
About the TransMedTech
The TransMedTech Institute (iTMT) aims to support innovation in medical technologies to meet the needs of end-users and the healthcare sector, in order to facilitate and accelerate their development and implementation in the healthcare system. Led by Polytechnique Montréal and four other founding institutions (Université de Montréal, CHU Sainte-Justine, CHUM and the Jewish General Hospital), the iTMT brings together more than fifty partner institutions, together maintaining a first-rate scientific infrastructure to support the development and validation of medical technologies. The TransMedTech Institute is supported by the Canada First Research Excellence Fund, the Ministère de l’Économie et de l’Innovation du Québec and the Fonds de recherche du Québec, as well as several other philanthropic, government, socio-economic and industrial university partners.
About Promaxo Inc.
Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 200 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. The Company has formed numerous long-term and strategic partnerships with investor groups and corporation as it drives commercialization of the Promaxo MRI system.
To learn more about the technology behind the MRI system and its scope, please visit: Promaxo.com.
LinkedIn: Promaxo
Twitter: @Promaxo
Facebook: Promaxo
Investors
Gilmartin Group
Vivian Cervantes
e: IR@promaxo.com
Intercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis, leading ICPT stock to plummet Friday.
Two marathon runners tell BBC Newsbeat about overcoming the odds to compete in the London Marathon.
Shares of Biogen (NASDAQ: BIIB) shot up as much as 37.1% this week, according to data from S&P Global Market Intelligence. The large-cap drugmaker with a market cap of $39 billion announced that its new Alzheimer's drug it developed in a partnership with Eisai showed tremendous promise in a clinical trial. As of 12:42 p.m. ET on Friday, shares of Biogen were up 35.5% this week.
A change of seasons is the perfect time to start — or shake up — your fitness routine. Join the October Start TODAY challenge to reap the health benefits of walking.
Dr. Anthony Fauci and his wife, Christine Grady, experienced millions in increased net worth as many Americans struggled during the pandemic, according to a watchdog group.
If approved, Sarepta's (SRPT) SRP-9001 will be the first gene therapy for DMD indication in the United States. The company seeks approval for gene therapy under the accelerated pathway.
Biohaven Pharmaceuticals (BHVN) suffers a setback as verdiperstat fails to meet the primary and secondary endpoints in an ALS study.
Would you leave your baby outside to sleep if we told you that it’s the best sleep they’ll ever get?
Dr Brian Hoeflinger is no stranger to seeing the gruesome affects of poor health habits
California Gov. Gavin Newsom (D) late Thursday night signed two bills that will ban cancer-linked “forever chemicals” from cosmetic products and textiles in the state beginning in 2025. The same evening, however, the governor vetoed a third bill that would have created a publicly accessible database of consumer items that contain these toxic compounds. The…
Anne Arundel County health officials are urging residents to get a flu shot and the latest COVID-19 booster shot.
Research shows that targeted, time-limited programs offer significant benefits for people struggling with anxiety and other problems.
Melissa Lima started experiencing a variety of really awful symptoms that included fatigue, brain fog, extreme anxiety and depression, weight gain, slow-healing cuts and scrapes, random rashes, sudden food allergies followed by intestinal issues, muscle and joint pain, and she developed an autoimmune disorder called Hashimoto's disease. She immediately felt better after her breast implants were removed. Sadly, however, many doctors deny that breast implant illness exists.View Entire Post ›
Catalyst Pharmaceuticals (CPRX) announces FDA approval of its sNDA for Firdapse to include pediatric patients for treating Lambert-Eaton myasthenic syndrome.
A professor of ophthalmology warns that allowing optometrists to perform certain surgeries without adequate training could lead to more health complications.
Nursing homes patients had to be evacuated after Hurricane Ian cut access to safe water supplies. AP Photo/John RaouxHurricane Ian, one of the most powerful storms to hit the U.S., tore part of the roof off a hospital in Port Charlotte, Florida, and flooded the building’s lower level emergency room, sending staff scrambling to move patients as water poured in. At least nine hospitals and dozens of nursing homes had to transfer patients after losing access to clean water because of the storm. Hea
A neurosurgeon on TikTok has revealed five things you should never do to have a healthy brain.Source: SWNS